What is Equinom?
Equinom operates at the vanguard of agrifood innovation, utilizing its proprietary Manna technology platform to redefine the nutritional and functional profiles of primary source crops like pea and soy. By leveraging advanced algorithms to characterize biochemical and genomic traits, the company develops seeds that require minimal processing, thereby enhancing taste and protein content while reducing the complexity of food manufacturing. This technological edge positions Equinom as a critical partner for food companies seeking to meet the surging consumer demand for sustainable, affordable, and high-quality meat and dairy alternatives. By bypassing genetic modification, Equinom provides a clean-label solution that addresses both environmental concerns and the economic pressures of modern food production.
How much funding has Equinom raised?
Equinom has raised a total of $73M across 5 funding rounds:
Series A
$4M
Other Financing Round
$4M
Series B
$10M
Series C
$20M
Other Financing Round
$35M
Series A (2017): $4M with participation from Fortissimo Capital
Other Financing Round (2018): $4M led by Fortissimo Capital
Series B (2020): $10M supported by Fortissimo Capital, BASF Venture Capital, Roquette, and Trendlines Group
Series C (2021): $20M featuring Phoenix Group, Maverick, BASF Venture Capital, Trendlines, and Fortissimo
Other Financing Round (2022): $35M backed by Praesidium and Synthesis Capital
Key Investors in Equinom
BASF Venture Capital
The corporate venture capital arm of the BASF Group, focusing on strategic investments in biotechnology and circular economy initiatives that align with global research interests.
Trendlines Group
An investment firm that discovers and incubates innovation-based medtech and agrifood technologies, providing hands-on support from development to business building.
Synthesis Capital
A venture capital firm specializing in the food technology sector, with a focus on supporting founders who are transforming the food system through advanced biotechnology and alternative proteins.
What's next for Equinom?
With the recent infusion of $35M, Equinom is well-positioned to transition into a phase of rapid commercial expansion and global market penetration. The strategic focus will likely center on scaling the deployment of its Manna-optimized seeds to meet the requirements of large-scale food processors and international distributors. As the company matures, it is expected to deepen its integration within the global food ecosystem, potentially exploring new crop varieties and expanding its research capabilities to further optimize the efficiency of plant-based protein production. The continued support from institutional investors suggests a long-term commitment to establishing Equinom as the foundational technology provider for the next generation of sustainable food products.
See full Equinom company page
